INSR and Hyperinsulinemia: Based on these reports and our present data, we suggested that the heterozygosity of the orthologous mutation with the kinase domain of the IR gene leads to moderate insulin resistance with hyperinsulinemia, but does not lead to the development of hyperglycaemia in mice or humans.